The neurobiology of ADHD is rooted in dysregulation across frontostriatal circuits, particularly involving the prefrontal cortex, basal ganglia, and associated dopaminergic and noradrenergic pathways. These networks are central to executive functioning, which includes attention regulation, working memory, cognitive flexibility, and inhibitory control.

 

Dopamine plays a key role in motivation, reward processing, and the prioritisation of stimuli. In individuals with ADHD, reduced dopaminergic signalling is associated with diminished capacity to sustain attention on tasks perceived as low in immediate reward. This contributes to a pattern often described as “interest-based attention,” where engagement is strong for novel or stimulating activities but significantly reduced for routine or repetitive tasks.

 

Noradrenaline contributes to arousal and attentional stability. Dysregulation within this system can result in fluctuations in alertness, leading to inconsistent cognitive performance. Together, these neurochemical differences create the characteristic variability seen in ADHD, where individuals may perform well in some contexts but struggle markedly in others.

 

Functional imaging studies have demonstrated reduced activation in the prefrontal cortex during tasks requiring sustained attention or inhibition. Connectivity between cortical and subcortical regions is also altered, affecting the coordination of goal-directed behaviour. These findings support the conceptualisation of ADHD as a disorder of network efficiency rather than structural deficit.

 

Executive dysfunction is a defining feature. Individuals may understand what needs to be done yet experience significant difficulty initiating or maintaining action. This disconnect between intention and execution is often misinterpreted as lack of motivation, when it more accurately reflects underlying neurocognitive differences.

 

Emotional regulation is increasingly recognised as central to ADHD. Heightened reactivity, rapid mood shifts, and difficulty returning to baseline following stress are common. These features are influenced by both neurobiological mechanisms and the cumulative psychological impact of long-term functional challenges.

 

ADHD frequently co-occurs with conditions such as anxiety, depression, and substance use disorders. These comorbidities can obscure the underlying diagnosis and complicate treatment pathways. A comprehensive, individualised assessment is therefore essential.

 

Understanding ADHD through a neurobiological framework reduces stigma and shifts the narrative away from behavioural judgement. It highlights the importance of targeted, evidence-based interventions designed to support cognitive functioning and improve long-term outcomes.